This inventor holds 1 USPTO granted patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: **Innovative Contributions of Takashi Seiki in Mammalian Feeding and Weight Regulation**
Introduction
Takashi Seiki, an inventive scientist based in Tsukuba, Japan, has made significant strides in the field of mammalian biology through his innovative research. His work primarily focuses on understanding the mechanisms influencing feeding behaviors and weight management in mammals, leading to potentially impactful therapeutic applications.
Latest Patents
Seiki holds a noteworthy patent titled "Methods of affecting feeding and weight in mammals by administration of relaxin-3." This patent outlines a groundbreaking discovery regarding relaxin-3, a polypeptide that exhibits feeding-stimulating activity, as well as the ability to increase both body and fat weight when administered intracerebroventricularly to rats. Through detailed observations, this invention showcases the potential of relaxin-3 in stimulating feeding and influencing weight gain, highlighting its significance in metabolic studies.
Career Highlights
Currently, Takashi Seiki is affiliated with Eisai R&D Management Co., Ltd., a company renowned for its commitment to innovative pharmaceutical research. His career reflects a dedication to advancing scientific understanding and developing therapeutic strategies, particularly for conditions related to obesity and metabolic disorders.
Collaborations
Throughout his career, Seiki has collaborated with notable researchers including Takayuki Hida and Tomoko Sekiya. These partnerships have further enriched his research efforts, enabling a multidisciplinary approach to addressing complex biological challenges.
Conclusion
Takashi Seiki’s contributions to the understanding of feeding regulation and weight management in mammals position him as an influential figure in the sphere of biological research. His innovative patent on relaxin-3 opens new avenues for therapeutic interventions aimed at combating obesity and related health issues, reflecting the impactful nature of his work in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile